News

Acquisitions jump BMS and Takeda into Top 10; Amgen and Gilead fall out

Also: more innovative cold-chain actions during the Covid-19 pandemic

1.3-million sq. ft to be added in the US and Europe

Move anticipates high-volume Covid-19 vaccine and therapeutics production, amidst other vial-production advances

Guidance for companies starting out on the commercialization path

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction

Position highlights the move toward more at-home services

Guidance for companies starting out on the commercialization path

Use of an eBV system can save months of re-verification work and >$100,000 in operational costs

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent

Pharma marketing will have to adjust to a new reality

The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions

A laudable goal is being addressed by unusual means, including taxpayer dollars

Former J&J executive will be the organization’s third-ever leader

California researchers needed to find a way to collaborate with their counterparts in Hong Kong

Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’

Quarles & Brady garners an innovative distinction

More packaging vendors are offering ‘curbside recyclable’ containers

Reasons for, and actions to take, when switching hub service providers

Milken Institute survey finds nearly 300 therapies and vaccines

Strains are showing in drug supplies consumed in treating infected patients

Carving out CGTs for payment systems involving government intervention may be an answer

DuPont/Cold Chain Technologies in thermal blankets; va-Q-tec in shipment tracking; big bucks for SkyCell

UPS and CVS Pharmacy collaborate for direct-to-patient delivery; but check out Matternet, UPS’ drone partner

Cellular and genetic therapies (CGTs) are a minor part of commercial business, but a growing part of research activity

Kit Check data show value of track-and-trace technology, especially during the Covid-19 pandemic

Revenue leakage in contracting and sales execution affects 95% of respondents